Hypothesis

1 Matching Annotations

Jul 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

1
1. scibot 18 Jul 2024
  
  in Public
  
  RRID:SCR_015654
  
  DOI: 10.1158/2767-9764.CRC-24-0252
  
  Resource: R package: lme4 (RRID:SCR_015654)
  
  Curator: @evieth
  
  SciCrunch record: RRID:SCR_015654
  
  What is this?
  
  DOI:10.1158/2767-9764.CRC-24-0252 RRID:SCR_015654
Visit annotations in context

Tags

DOI:10.1158/2767-9764.CRC-24-0252

RRID:SCR_015654

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11247952/